Wockhardt: R&D efforts kick start - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Wockhardt: R&D efforts kick start

Nov 22, 2001

Recently, Wockhardt announced filing application for conducting clinical trials on its anti-infective molecule, WCK-771.The company’s R&D initiative started some four years back. Though at a very early stage these seem to be bearing fruit. The company recently held an analyst meet to update mainly on this development. Wockhardt highlighted the molecule’s superior safety and efficacy over currently available drugs such as Vancomycin (Aventis Pharma) and Linezolid (Pharmacia). According to the company, globally there are only a few competing drugs, which are under clinical development for the above product. The prevailing market size for such a drug is in excess of US$ 1 bn. Considering that the molecule has just finished pre-clinical trials it would take another 6-9 months time to complete Phase I clinical trials.

Wockhardt informed that it has started exploring opportunities for out licensing the molecule. However, it expects final out licensing deal in between Phase I and Phase II trials i.e. in another 12-15 months time frame. Wockhardt said it also has another anti-infective molecule in its pipeline (WCK 919) and clinical trials on this are expected to start in a year’s time.

Though the company has made a good beginning, the pipeline is very pre-mature. It should be understood that chances of Phase I molecule finally succeeding are low and any earnings visibility even from out licensing the molecule is far fetched at this point of time. At the current market price of Rs 408, the stock trades at 14.5x FY02 expected earnings.

Equitymaster requests your view! Post a comment on "Wockhardt: R&D efforts kick start". Click here!

  

More Views on News

WOCKHARDT 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of WOCKHARDT for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of WOCKHARDT. Also includes updates on the valuation of WOCKHARDT.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Dec 6, 2021 03:15 PM

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WOCKHARDT WITH

MARKET STATS